Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/20686362

Cancer Biol. Ther. 2010 Oct 15 10 8 788-95

Download in:

View as

General Info

PMID
20686362